BiotechTube
Home/FerroptoCure/Osamu Nagano
ON

Osamu Nagano

Director, DDS., Ph.D.

FerroptoCure

Therapeutic Areas

Oncology

FerroptoCure Pipeline

DrugIndicationPhase
FC001Cancer (unspecified)Phase 1
FC004Cancer (unspecified)Preclinical

Leadership Team at FerroptoCure

YO
Yuji Otsuki
CEO, M.D., Ph.D.
HS
Hideyuki Saya
Director, M.D., Ph.D.
TN
Toru Natsume
Director, Ph.D. (CSO at RBI)
NN
Nobuhiro Nishiyama
Director, Ph.D.
View full FerroptoCure profile